Explaining neuroendocrine relationships in obesity |
|
|
|
|
|
Identifying high-risk individuals |
|
|
|
|
|
Communicating the risks and benefits of therapies with patients |
|
|
|
|
|
Applying the most recent obesity guidelines in my practice |
|
|
|
|
|
Selecting among emerging pharmacotherapies to treat obesity |
|
|
|
|
|
Appropriately referring patients for treatment or education |
|
|
|
|
|